Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with ...
New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-'749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDS ...
Governments and airlines are backing eVTOLs with policy and investments, and designs for their infrastructure are starting to ...
Co., Ltd. has recently obtained a utility model patent named "Power Testing System," with authorization announcement number CN223320487U, and an application date of August 2024. The core of this ...
Positive Phase 1 study showed safety, tolerability and a linear pharmacokinetic: pharmacodynamic: efficacy relationship (1: 1: 1)Planning ...
AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced that the first European participants have been randomized in ...
The growth of the Robo Advisor Market is driven by the increasing adoption of digital wealth management platforms, rising ...
These trail cameras went through our standardized testing protocol and months of in-field use before we picked our winner.
Cryptopolitan on MSN
UK’s Wayve starts testing self-driving features in Nissan vehicles
British startup Wayve has begun on-road trials in Japan with Nissan and is in talks with Nvidia over a possible $500 million ...
Ideal for industrial applications such as PV inverters, UPS systems, and semiconductor relays. Comparison between DOT-247 and ...
The past few months have seen announcements of prototype electric vehicles that don’t use inverters to produce three-phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback